Print

VRI01

Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers (VRI01)

Trial Details:

I/II Completed
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) March 01, 2014
LIPO-5,MVA-B,GTU-MultiHIV Protein Gag, Nef, Pol B; MVA Nef; Gag; Pol B; DNA Rev, Nef, Tat, Pol, Env B
MVA-B Viral Vector - Pox
LIPO-5 Protein
GTU-MultiHIV DNA
France 92
NCT02038842
http://www.clinicaltrials.gov/ct2/show/NCT02038842?term=hiv+and+vaccine&lup_s=01%2F07%2F2014&lup_d=14&show_rss=Y&sel_rss=mod14